These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12477273)

  • 1. What is the rationale for the use of granulocyte and granulocyte-macrophage colony-stimulating factors in the neonatal intensive care unit?
    La Gamma EF; De Castro MH
    Acta Paediatr Suppl; 2002; 91(438):109-16. PubMed ID: 12477273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. G-CSF and GM-CSF for treating or preventing neonatal infections.
    Carr R; Modi N; Doré C
    Cochrane Database Syst Rev; 2003; 2003(3):CD003066. PubMed ID: 12917944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloid colony-stimulating factors: use in the newborn.
    Sreenan C; Osiovich H
    Arch Pediatr Adolesc Med; 1999 Sep; 153(9):984-8. PubMed ID: 10482217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sepsis in babies: should we stimulate the phagocytes?
    Shann F
    Lancet; 2009 Jan; 373(9659):188-90. PubMed ID: 19150690
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of recombinant granulocyte colony-stimulating factor, recombinant human granulocyte-macrophage colony-stimulating factor and placebo for treatment of septic preterm infants.
    Ahmad A; Laborada G; Bussel J; Nesin M
    Pediatr Infect Dis J; 2002 Nov; 21(11):1061-5. PubMed ID: 12442030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal neutropenia: what diagnostic evaluation is needed and when is treatment recommended?
    Del Vecchio A; Christensen RD
    Early Hum Dev; 2012 May; 88 Suppl 2():S19-24. PubMed ID: 22633505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy in the prophylaxis and treatment of neonatal sepsis.
    Suri M; Harrison L; Van de Ven C; Cairo MS
    Curr Opin Pediatr; 2003 Apr; 15(2):155-60. PubMed ID: 12640271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of G-CSF GM-CSF in the management of infections in preterm newborns: an update.
    Castagnola E; Dufour C
    Early Hum Dev; 2014 Sep; 90 Suppl 2():S15-7. PubMed ID: 25220119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential use of granulocyte colon-stimulating factor and granulocyte-macrophage colony-stimulating factor in neonates.
    Bracho F; Goldman S; Cairo MS
    Curr Opin Hematol; 1998 May; 5(3):215-20. PubMed ID: 9664163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The current role of colony-stimulating factors in prevention and treatment of neonatal sepsis.
    Banerjea MC; Speer CP
    Semin Neonatol; 2002 Aug; 7(4):335-49. PubMed ID: 12401303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caution about trial methodology and statistics.
    Degraeuwe PL; Nieman FH
    Pediatrics; 2001 Dec; 108(6):1383-4. PubMed ID: 11731667
    [No Abstract]   [Full Text] [Related]  

  • 12. Immune stimulation in sepsis: to be or not to be?
    Napolitano LM
    Chest; 2005 Jun; 127(6):1882-5. PubMed ID: 15947295
    [No Abstract]   [Full Text] [Related]  

  • 13. Randomized, double-blinded, placebo-controlled trial of early administration of recombinant human granulocyte colony-stimulating factor to non-neutropenic preterm newborns between 33 and 36 weeks with presumed sepsis.
    Kücüködük S; Sezer T; Yildiran A; Albayrak D
    Scand J Infect Dis; 2002; 34(12):893-7. PubMed ID: 12587621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocyte macrophage-colony stimulating factor (GM-CSF) in neonatal neutropenia.
    Ray M; Mukhopadhyay K; Narang A
    Indian J Pediatr; 2000 Jan; 67(1):67-8. PubMed ID: 10832225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune-mediated neutropenia in the neonate.
    Maheshwari A; Christensen RD; Calhoun DA
    Acta Paediatr Suppl; 2002; 91(438):98-103. PubMed ID: 12477271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloid hematopoietic growth factors and their role in prevention and/or treatment of neonatal sepsis.
    Parravicini E; van de Ven C; Anderson L; Cairo MS
    Transfus Med Rev; 2002 Jan; 16(1):11-24. PubMed ID: 11788926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant human granulocyte colony-stimulating factor in preterm neonates with sepsis and relative neutropenia: a randomized, single-blind, non-placebo-controlled trial.
    Gathwala G; Walia M; Bala H; Singh S
    J Trop Pediatr; 2012 Feb; 58(1):12-8. PubMed ID: 21296862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hematopoietic growth factors in prevention and therapy of infectious complications in premature and newborn infants].
    Lehrnbecher T
    Z Geburtshilfe Neonatol; 2001; 205(5):167-73. PubMed ID: 11727663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical use of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in neutropenia associated with malignancy.
    Lifton R; Bennett JM
    Hematol Oncol Clin North Am; 1996 Aug; 10(4):825-39. PubMed ID: 8811304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocyte-macrophage colony stimulating factor administered as prophylaxis for reduction of sepsis in extremely preterm, small for gestational age neonates (the PROGRAMS trial): a single-blind, multicentre, randomised controlled trial.
    Carr R; Brocklehurst P; Doré CJ; Modi N
    Lancet; 2009 Jan; 373(9659):226-33. PubMed ID: 19150703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.